Sargramostim (EMGRAST-M vial) is a hematopoietic agent, prescribed for severe, life-threatening infections after chemotherapy for acute myelogenous leukemia (AML). It is also used for bone marrow transplantation. It stimulates the production of white blood cells in bone marrow.
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak with a healthcare professional.
EMGRAST-M vial - Emcure Pharmaceuticals Ltd. (Gennova)
EMGRAST-M vial Injection
Generic : Sargramostim
₹
3582
500mcg
1Vial
When is EMGRAST-M vial prescribed?
It is prescribed for -